Stoxline.com

Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations  |  Forex Crypto

Oragenics Inc (OGEN)

1.065   -0.095 (-8.19%) 02-25 12:19
Open: 1.12 Pre. Close: 1.16
High: 1.14 Low: 1.05
Volume: 3,720,756 Market Cap: 116M
Oragenics, Inc. is a biopharmaceutical company, which focuses on the development of novel antibiotics and treatments against infectious disease and oral mucositis. The company is headquartered in Tampa, Florida and currently employs 12 full-time employees. The firm is focused on offering antibiotics against infectious disease and on developing treatments for oral mucositis. The company is engaged in developing its antibiotic product candidate, MU1140, as well as other homolog antibiotic product candidates; researching AG013 in connection with the treatment of Oral Mucositis; commercializing its ProBiora3 probiotic products, and has other product candidates for out licensing or partnering. MU1140 is an antibiotic that is produced by the parent of the SMaRT strain. ProBiora3 is a blend of three naturally occurring strains of beneficial bacteria, including Streptococcus oralis KJ3, Streptococcus uberis KJ2 and Streptococcus rattus JH145. LPT3-04 is a compound, which is consumed in the human diet in small amounts and results in dose-dependent weight loss in experimental animal models.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 1.232 - 1.239 1.239 - 1.245
Low: 1.132 - 1.141 1.141 - 1.149
Close: 1.148 - 1.16 1.16 - 1.171

Technical analysis

as of: 2021-02-25 11:49:14 AM
Overall:       
Stoxline posted a SELL today, same as yesterday. Downward movement continues.
Target: Six months: 1.68     One year: 2.10
Support: Support1: 0.86    Support2: 0.72
Resistance: Resistance1: 1.44    Resistance2: 1.80
Pivot: 1.26
Moving Average: MA(5): 1.18     MA(20): 1.18
MA(100): 0.69     MA(250): 0.70
MACD: MACD(12,26): 0.08     Signal(9): 0.12
Stochastic oscillator: %K(14,3): 20.39     %D(3): 28.31
RSI: RSI(14): 47.62
52-week: High: 2.09  Low: 0.36  Change(%): 42.7
Average Vol(K): 3-Month: 2642174  10-Days: 903548

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and BULLISH in mid-long term.
OGEN has closed above bottom band by 18.0%. Bollinger Bands are 101.3% wider than normal. The large width of the bands suggest high volatility as compared to OGEN's normal range. The bands have been in this wide range for 12 bars. This is a sign that the current trend might continue.

Headline News

Mon, 22 Feb 2021
Biotech firm raises $20 million, sees progress on Covid-19 vaccine - St Pete Catalyst

Sun, 21 Feb 2021
Premarket Mover: Oragenics Inc (OGEN) Up 10.77% - InvestorsObserver

Fri, 12 Feb 2021
Oragenics Announces Recent Capital Raise and Warrant Exercises Totaling $21.9 Million and the Redemption of Its Series C Preferred Stock - Yahoo Finance

Tue, 09 Feb 2021
50 Stocks Moving in Tuesday's Pre-Market Session - Benzinga

Tue, 09 Feb 2021
Oragenics Inc (OGEN) Up 33.08% in Premarket Trading - InvestorsObserver

Mon, 08 Feb 2021
Premarket Mover: Oragenics Inc (OGEN) Up 11.43% - InvestorsObserver

Financial Analysis

Growth
Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency n/a
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Price to Book Value: Outperform Discounted cash flow: Outperform
Return on Assets: Underperform Price to Earnings: Underperform
Return on Equity: Underperform Debt to Equity: Neutral
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  AMEX
Sector:  Healthcare
Industry:  Biotechnology
Shares Out. (M) 61
Shares Float (M) 42
% Held by Insiders 4.96
% Held by Institutions 19.36
Shares Short (K) 2,310
Shares Short P. Month (K) 1,600

Stock Financials

EPS -0.523
EPS Est This Year -0.180
EPS Est Next Year -0.230
Book Value (p.s.) 0.030
Profit Margin
Operating Margin
Return on Assets (ttm) -83.5
Return on Equity (ttm) -150.3
Qtrly Rev. Growth
Gross Profit (p.s.)
Sales Per Share
EBITDA (p.s.) -0.412
Qtrly Earnings Growth
Operating Cash Flow (M) -16
Levered Free Cash Flow (M) -7

Stock Valuations

PE Ratio -2.05
PEG Ratio
Price to Book value 35.67
Price to Sales
Price to Cash Flow -4.08

Stock Dividends

Dividend
Forward Dividend
Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
7 Binary Options
Your Ad Here
android_stock_chart
Stock Chart
stoxline_lite
Stoxline Lite
stoxline_pro
Stoxline Pro
Option_Calculator
Option Calculator
(c) 2006-2020 Stoxline.com | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.